• No results found

18 results with keyword: 'early stage breast cancer patients impact treatment survival'

Early-Stage Young Breast Cancer Patients: Impact of Local Treatment on Survival

In this study, we investigated the effect of type of local treatment (BCT vs. mastectomy) on overall survival (OS) of women aged <40 years with early-stage breast cancer..

Protected

N/A

7
0
0
2021
High nuclear MSK1 is associated with longer survival in breast cancer patients

Conclusions High MSK1 is associated with improved breast cancer-specific survival in early stage invasive breast cancer patients, and has additional prognostic value in

Protected

N/A

9
0
0
2020
For the Design, Installation, Commissioning & Maintenance of Fixed Gaseous Fire Suppression Systems

a) There should be evidence that the organisation has the ability to successfully interpret system design requirements provided by the system designer. b) The

Protected

N/A

37
0
0
2021
Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer

Early detection of lung cancer is critical for NSCLC patients, since early-stage patients have much longer survival than late-stage patients. Unfortunately, conventional lung cancer

Protected

N/A

9
0
0
2020
Nonprofit Marketing. Dr. Chun-Tuan Debbie Chang

(broader) => a management orientation which helps a nonprofit look beyond its internal operations and programs to the external world that affects

Protected

N/A

52
0
0
2022
Chemotherapy-associated fatigue and cognitive impairment: a proposed SWOG clinical trial. Patient A. Patient A

patients with early stage breast cancer and chemotherapy-related fatigue Behavioral and Health Outcomes Committee. Committee on Special Populations Breast

Protected

N/A

15
0
0
2021
Cooper Cancer Institute 2011 Statistical Annual Report

Stage at diagnosis at Cooper compares to national data, with the majority of breast cancer patients being diagnosed as early as Stage 0, Stage 1 or Stage 2 cancers. Breast

Protected

N/A

14
0
0
2021
SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WHO OPTED OUT OF CANCER-SPECIFIC THERAPY

In order to investigate the impact on survival in patients who specifically opted out of cancer- specific treatment, we compared the survival rates between patients with Stage 1 to

Protected

N/A

6
0
0
2020
Breast-Conserving Surgery in Older Patients with Invasive Breast Cancer: Current Patterns of Treatment Across the United States

To select a subgroup of patients with early- stage breast cancer, given that surgical treatment strategies are typically dependent on disease stage, we applied a pre- viously

Protected

N/A

11
0
0
2021
Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis

Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based

Protected

N/A

14
0
0
2020
Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer

Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer..

Protected

N/A

9
0
0
2021
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

In the present study, women undergoing BCT for early stage invasive breast cancer demonstrated significantly shorter breast cancer specific and overall survival if they carried

Protected

N/A

10
0
0
2020
Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm

Introduction: The impact of visceral pleural invasion (VPI) on survival remains controversial for patients with early stage non-small cell lung cancer (NSCLC).. This

Protected

N/A

8
0
0
2020
Breast implants following mastectomy in women with early stage breast cancer: prevalence and impact on survival

Petit JY, Le MG, Mouriesse H, Rietjens M, Gill P, Contesso G, Leh- mann A: Can breast reconstruction with gel-filled silicone implants increase the risk of death and second

Protected

N/A

10
0
0
2020
CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient

Figure 1: High CTMP expression is associated with poor survival and early recurrence in breast cancer patients.. Representative IHC images of breast cancer specimens showing

Protected

N/A

12
0
0
2020
A SAMPLE REPORT. Benchmarking to Improve An Examination of Districts Processes in: INFORMATION TECHNOLOGY (IT)

Each metric within the category has a graph that shows your district compared against all other participants, districts of similar size (over/under 100K students), and a select

Protected

N/A

54
0
0
2021
Emerging Diagnostic and Prognostic Biomarkers of Triple
Negative Breast Cancer

However, the survival rate of breast cancer patients can be enhanced by early detection of cancer through effective prognostic markers [5].. Clinically, breast cancer has

Protected

N/A

5
0
0
2020
AMA Aboriginal and Torres Strait Islander Health Audit Report 2012: Progress to Date and Challenges that Remain

Mainstream primary care services, such as private general practices and community health clinics, also have a strong potential to improve the quality of the primary care they

Protected

N/A

24
0
0
2021

Upload more documents and download any material studies right away!